Role of Bone-Modifying Agents in Multiple Myeloma: ASCO Clinical Practice Guideline Update

January 29, 2018 – As reported in the Journal of Clinical Oncology by Kenneth Anderson, MD, of Dana-Farber Cancer Institute, and colleagues, ASCO has issued a clinical practice guideline update on the role of bone-modifying agents in multiple myeloma. The update was informed by an expert panel systematic literature review including 35 relevant studies. The expert panel was co-chaired by Dr. Anderson and Robert A. Kyle, MD, of Mayo Clinic, Rochester. Key … (leggi tutto)